Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis

Atherosclerosis

Volumn 245, Issue , 2016, Pages 139-142

  López Mejías, Raquel ^a   Genre, Fernanda ^a   Remuzgo Martínez, Sara ^a   Robledo, Gema ^b   Llorca, Javier ^c   Corrales, Alfonso ^a   González Juanatey, Carlos ^d   Ubilla, Begoña ^a   Mijares, Verónica ^a   Pina, Trinitario ^a   Blanco, Ricardo ^a   Castañeda, Santos ^e   Martín, Javier ^b   González Gay, Miguel A ^a,f,g  

^a Division of Epidemiology   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d Hospital Lucus Augusti   (Spain)

^e HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g University Hospital of Santiago de Compostela   (Spain)

Author keywords

Atherosclerosis; Carotid plaques; Polymorphisms; Rheumatoid arthritis; Vitamin D receptor

Indexed keywords

C REACTIVE PROTEIN; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; DNA; VDR PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CAROTID ATHEROSCLEROSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SPANIARD; ALLELE; ATHEROSCLEROSIS; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METABOLISM; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RETROSPECTIVE STUDIES;

EID: 84951743731     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.12.011     Document Type: Article

References (25)

1. Gonzalez-Gay M.A., Gonzalez-Juanatey C., Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin. Arthritis Rheum. 2005, 35:8-17.
2. van Halm V.P., Peters M.J., Voskuyl A.E., et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE investigation. Ann. Rheum. Dis. 2009, 68:1395-1400.
3. Peters M.J., van Halm V.P., Voskuyl A.E., et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum. 2009, 61:1571-1579.
4. Nurmohamed M.T., Kitas G. Cardiovascular risk in rheumatoid arthritis and diabetes: how does it compare and when does it start?. Ann. Rheum. Dis. 2011, 70:881-883.
5. Nielen M.M., van Sijl A.M., Peters M.J., et al. Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care. BMC Musculoskelet. Disord. 2012, 13:150.
6. Urruticoechea A., Martín-Martínez M.A., Castañeda S., et al. Vitamin D deficiency in chronic inflammatory rheumatic diseases. Results of the cardiovascular in rheumatology [CARMA] study. Arthritis Res. Ther. 2015, 17:211.
7. Souberbielle J.C., Body J.J., Lappe J.M., et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun. Rev. 2010, 9:709-715.
8. Patel S., Farragher T., Berry J., et al. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007, 56:2143-2149.
9. Gonzalez-Gay M.A., Gonzalez-Juanatey C., Lopez-Diaz M.J., et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2007, 57:125-132.
10. Dessein P.H., Norton G.R., Woodiwiss A.J., Joffe B.I., Wolfe F. Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J. Rheumatol. 2007, 34:943-951.
11. López-Mejías R., García-Bermúdez M., González-Juanatey C., et al. NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 2012, 224:426-429.
12. Rodríguez-Rodríguez L., González-Juanatey C., Palomino-Morales R., et al. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 2011, 216:125-130.
13. Emanuele E. Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises. Atherosclerosis 2011, 216:21e2.
14. Ferrarezi D.A., Bellili-Muñoz N., Dubois-Laforgue D., et al. Allelic variations of the vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in type 2 diabetics: the DIABHYCAR prospective study. Diabetes Metab. 2013, 39:263-270.
15. Gonzalez-Juanatey C., Llorca J., Martin J., Gonzalez-Gay M.A. Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin. Arthritis Rheum. 2009, 38:366-371.
16. Gonzalez-Gay M.A., Gonzalez-Juanatey C., Vazquez-Rodriguez T.R., Martin J., Llorca J. Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin. Arthritis Rheum. 2008, 38:67-70.
17. Aletaha D., Neogi T., Silman A.J., et al. 2010 rheumatoid arthritis classification criteria: an american college of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2010, 62:2569-2581.
18. Little J., Higgins J.P., Ioannidis J.P., et al. STrengthening the REporting of Genetic Association studies (STREGA)-an extension of the STROBE statement. Eur. J. Clin. Investig. 2009, 39:247-266.
19. Corrales A., González-Juanatey C., Peiró M.E., et al. Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann. Rheum. Dis. 2014, 73:722-727.
20. Gonzalez-Juanatey C., Llorca J., Garcia-Porrua C., Martin J., Gonzalez-Gay M.A. Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Rheum. 2006, 55:150-153.
21. Touboul P.J., Hennerici M.G., Meairs S., et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the advisory board of the 3rd and 4th watching the risk symposium, 13th and 15th European stroke conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc. Dis. 2007, 23:75-80.
22. Naredo E., Möller I., Gutiérrez M., et al. Multi-examiner reliability of automated radio frequency-based ultrasound measurements of common carotid intima-media thickness in rheumatoid arthritis. Rheumatol. Oxf. 2011, 50:1860-1864.
23. Ardesia M., Ferlazzo G., Fries W. Vitamin D and inflammatory bowel disease. Biomed. Res. Int. 2015, 2015:470805.
24. Yin K., Agrawal D.K. Vitamin D and inflammatory diseases. J. Inflamm. Res. 2014, 7:69-87.
25. Al-Daghri N.M., Guerini F.R., Al-Attas O.S., et al. Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PLoS One 2014, 9:e102141.